These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2101136)

  • 21. Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease.
    Manuelidis L; Zaitsev I; Koni P; Lu ZY; Flavell RA; Fritch W
    J Virol; 2000 Sep; 74(18):8614-22. PubMed ID: 10954563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro transformation elicited by Creutzfeldt-Jakob-infected brain material.
    Oleszak EL; Manuelidis L; Manuelidis EE
    J Neuropathol Exp Neurol; 1986 Sep; 45(5):489-502. PubMed ID: 3528396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential retroviral RNAs in Creutzfeldt-Jakob disease.
    Murdoch GH; Sklaviadis T; Manuelidis EE; Manuelidis L
    J Virol; 1990 Apr; 64(4):1477-86. PubMed ID: 2108258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.
    Brown P; Cervenáková L; McShane LM; Barber P; Rubenstein R; Drohan WN
    Transfusion; 1999; 39(11-12):1169-78. PubMed ID: 10604242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host genetic control of incubation periods of Creutzfeldt-Jakob disease in mice.
    Mohri S; Tateishi J
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1391-400. PubMed ID: 2659733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ultrastructural diversity of scrapie-associated fibrils isolated from experimental scrapie and Creutzfeldt-Jakob disease.
    Liberski PP; Brown P; Xiao SY; Gajdusek DC
    J Comp Pathol; 1991 Nov; 105(4):377-86. PubMed ID: 1770176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease.
    Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC
    Acta Neuropathol; 1990; 79(4):349-54. PubMed ID: 2160182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen.
    Tateishi J; Tashima T; Kitamoto T
    Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease.
    Brown P; Wolff A; Gajdusek DC
    Neurology; 1990 Jun; 40(6):887-90. PubMed ID: 1693181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes.
    Bockman JM; Prusiner SB; Tateishi J; Kingsbury DT
    Ann Neurol; 1987 Jun; 21(6):589-95. PubMed ID: 3300520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spiroplasma-like inclusions in Creutzfeldt-Jakob disease.
    Bastian FO
    Arch Pathol Lab Med; 1979 Dec; 103(13):665-9. PubMed ID: 389196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease.
    Connolly JH; Allen IV; Dermott E
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1459-60. PubMed ID: 3069961
    [No Abstract]   [Full Text] [Related]  

  • 35. Phenolized formalin may not inactivate Creutzfeldt-Jakob disease infectivity.
    Taylor DM
    Neuropathol Appl Neurobiol; 1989; 15(6):585-6. PubMed ID: 2693993
    [No Abstract]   [Full Text] [Related]  

  • 36. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease.
    Liberski PP; Budka H; Sluga E; Barcikowska M; Kwiecinski H
    Eur J Epidemiol; 1991 Sep; 7(5):551-5. PubMed ID: 1761114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth factor production by Creutzfeldt-Jakob disease cell lines.
    Oleszak EL; Murdoch G; Manuelidis L; Manuelidis EE
    J Virol; 1988 Sep; 62(9):3103-8. PubMed ID: 3043023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical properties of the Creutzfeldt-Jakob disease agent.
    Sklaviadis TK; Manuelidis L; Manuelidis EE
    J Virol; 1989 Mar; 63(3):1212-22. PubMed ID: 2492609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic control of scrapie and Creutzfeldt-Jakob disease in mice.
    Kingsbury DT; Kasper KC; Stites DP; Watson JD; Hogan RN; Prusiner SB
    J Immunol; 1983 Jul; 131(1):491-6. PubMed ID: 6408182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.